Immersive Sensory Projections for Hospitalized Patients
ConditionHospitalism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
About this trial
The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years ;
Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours;
Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase;
Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires;
Disqualifiers
Deaf or blind patient;
Asthmatic patient with background treatment;
Epileptic patient or known history of convulsion;
Known allergy or intolerance to essential oils or to a component of essential oils;
Trial design
Design model
Parallel
Treatments tested in this trial
Hospitalization in intensive care or continuing care unit
Procedure/SurgeryHospitalization in intensive care or continuing care unit for medical reasons or surgery, conscious or unconscious under mechanical ventilation. Resuscitation patients are then cared for in a continuing care unit.
Treatment groups
208 Participants
are divided into 2 treatment groupsGroup A: Immersive sensory projectionsExperimental treatment 1 intervention
Group B: No immersive sensory projectionsActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
REAnimation Patient Discomfort Questionnaire
Overall score on the REAnimation Patient Discomfort Questionnaire at the end-of-study visit
Time frame
2 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator
Source ClinicalTrials.gov